|
|
|
|
|
Tuesday, February 1, 2011
|
7:30 am -
8:30 am
|
|
8:30 am -
11:30 am
|
By attending this workshop attendees will learn the following:
- Optimizing the Use of Genetic Testing to Advance Personalized Medicine, Cut Unnecessary Health Care Spending and Increase Efficiencies
- How comparable are patient populations?
- How decision-support systems help "connect the dots" for payers and physicians regarding the available scientific literature and insurers' coverage criteria for genomic tests
- Understand why it is critical to focus on adoption of methods and tools for personalization of care, easy to access and use at the point of care
- Applying pharmacogenomics to health care and the potential to provide numerous benefits for more accurate drug dosing, improving safety of therapies and less waste in the system
- Mapping human genome to increase knowledge, resources and technology in medical science
- Optimizing the Use of Molecular Testing to Advance Personalized Medicine, Reduce Unnecessary Use of Health Care Resources and Increase Efficiencies
- Challenges the lack of data on health outcomes has had on the use of genetic testing
- What is the clinical utility of personalized medicine?
|
|
|
|
11:30 am -
12:30 pm
|
|
12:30 pm -
12:45 pm
|
|
12:45 pm -
1:45 pm
|
- Uncover how the $1.1 billion ARRA funds being disseminated?
- Discuss the different types of treatments comparative effectiveness research compare?
- Should comparative effectiveness research include measures of cost?
- Discuss how the HHS awards will help better leverage data quality and ultimately improve primary care services for low-income and underinsured populations
- Explore how comparative effectiveness research is helping to shape how states are designing patient-centered practices
|
|
|
|
1:45 pm -
3:00 pm
|
| This session will explore the interface of comparative effectiveness findings and the challenges of implementation at the practice and patient level. CER will influence both clinical decision making and determination of medical necessity and coverage, coupled with pressure from quality initiatives and lean concepts. Science and data will begin to supersede the politics of special interests and disciplines’ pet products and procedures to help guide optimal effective treatment choices. They will likely also stimulate more consistent Utilization Management decisions across payers, geographies and specialties. We will also explore the oft ignored aspect of real-life implementation, including the everyday day challenges of making CER-based changes within practice and the critical but thorny issue of obtaining timely feedback from patients. In this way we will move this discussion from the ethereal stratosphere to real life practice and address issues of implementation, disparity and ethics. |
| Moderator: |
|
Susan Dentzer
Editor-in-Chief
Health Affairs
 View Biography
|
| Panelists: |
|
Dennis A. Robbins, PhD, MPH
Adjunct Professor, Graduate School of Public Policy, Pepperdine University;
Advisory Board Member, National Research Network
View Biography
|
|
|
Elizabeth E. Stewart, PhD, MBA
Research Scientist
American Academy of Family Physicians National Research Network (AAFP NRN)
|
|
Patricia Hinton Walker, PhD, RN, FAAN
Vice President for Nursing Policy, Uniformed Services University of the Health Sciences
Chair, Executive Leadership, TIGER III (Technology Informatics Guiding Education Reform)
View Biography
|
| Other Thought Leaders TBD |
|
|
3:00 pm -
3:30 pm
|
|
3:30 pm -
4:30 pm
|
- Hear how the FDA is engaging in comparative effectiveness research and collaborating with outside groups to investigate FDA data
- Discuss the goals to define subsets of populations, disease research areas and areas for product classes
- Learn of the clinical trial design strategies to support comparative effectiveness research and personalized medicine
|
|
|
|
4:30 pm -
5:30 pm
|
- Why clinical trials are an important tool for comparative effectiveness research
- Designing more informative clinical trials for patients, clinicians and payers
- Understand the challenges in addressing multiple end user information needs
- What are the implementation challenges and solutions for clinical trials in comparative effectiveness research
|
|
|
Penny Mohr, MA
Vice President for Programs
Center for Medical Technology Policy
View Biography
|
|
|
|
5:30 pm -
6:30 pm
|
|
|
|
|
|
|
Printer Friendly
Email A Colleague
Bookmark Page
